| For      the Quarterly Period Ended December 31, 2007 | Commission      FileNumber      1-11700 |
|-------------------------------------------------------|-----------------------------------------|

| Delaware                     | 04-2869857                    |
|------------------------------|-------------------------------|
| (State      of Organization) | (I.R.S.      Employer Number) |

| 9033      Red Branch Road, Columbia, Maryland 21045-2105 |
|----------------------------------------------------------|
| (Address      of principal executive offices, ZipCode)   |

| (443)      367 5500                                        |
|------------------------------------------------------------|
| (Issuer’s      telephone number, including areacode) |

----

|                           |                                   |                                                                                                       |        PageNumber |
|--------------------------------|----------------------------------------|------------------------------------------------------------------------------------------------------------|------------------------|
|        PART      I.  |        FINANCIAL      INFORMATION |                                                                                                       |
|                           | Item      1.                           | Financial      Statements                                                                                  |                   |
|                           |                                   |                                                                                                       |                   |
|                           |                                   | Consolidated      Balance Sheets; December 31, 2007 (unaudited) and September 30,      2007                | 3                      |
|                           |                                   |                                                                                                       |                   |
|                           |                                   | Consolidated      Statements of Operations; Three Months Ended December 31, 2007 (unaudited)      and 2006 | 5                      |
|                           |                                   |                                                                                                       |                   |
|                           |                                   | Consolidated      Statements of Cash Flows; Three Months Ended December 31, 2007(unaudited)      and 2006  | 6                      |
|                           |                                   |                                                                                                       |                   |
|                           |                                   | Notes      to Consolidated Financial Statements                                                            | 7                      |
|                           |                                   |                                                                                                       |                   |
|                           | Item      2.                           | Management’s      Discussion and Analysis of Financial and Results of    Operations                  | 13                     |
|                           |                                   |                                                                                                       |                   |
|                           | Item      3.                           | Controls      and Procedures                                                                               | 17                     |
|                           |                                   |                                                                                                       |
| PART      II.                  | OTHER      INFORMATION                 |                                                                                                       |
|                           |                                   |                                                                                                       |                   |
|                           | Item      2.                           | Unregistered      Sales of Equity Securities and Use Of Proceeds                                           | 17                     |
|                           |                                   |                                                                                                       |                   |
|                           | Item      6.                           | Exhibits                                                                                                   | 18                     |
|                           |                                   |                                                                                                       |                   |
|        SIGNATURES         | 19                                     |
|                           |                                   |
|        CERTIFICATIONS     |                                   |

----

|                                                                                                                                                                                 |   | December      31,2007 |      |   | September      30,2007 |   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|-----------------------|-----------|--------|------------------------|--------|
|                                                                                                                                                                                 |   | (unaudited)           |      |   |                   |   |
| ASSETS                                                                                                                                                                               |   |                  |      |   |                   |   |
|                                                                                                                                                                                 |   |                  |      |   |                   |   |
| CURRENT      ASSETS:                                                                                                                                                                 |   |                  |      |   |                   |   |
| Cash      and cash equivalents                                                                                                                                                       |   | $                     | 264,182   |   |                   | $      | 6,592 |   |
| Accounts      receivable, less allowance for                                                                                                                                         |   |                  |      |   |                   |   |   |   |
|     doubtful      accounts of $84,316 and $51,316 at                                                                                                             |   |                  |      |   |                   |   |   |   |
|     December      31, 2007 and September 30, 2007, respectively                                                                                                  |   |                  | 897,938   |   |                   |   | 1,000,652 |   |
| Inventories,      net                                                                                                                                                                |   |                  | 2,174,622 |   |                   |   | 2,554,881 |   |
| Current      portion of Note Receivable                                                                                                                                              |   |                  | 210,000   |   |                   |   |   |   |
| Prepaid      expenses and other current assets                                                                                                                                       |   |                  | 287,119   |   |                   |   | 265,633 |   |
| Assets      Held for Sale                                                                                                                                                            |   |                  | --        |   |                   |   | 5,183 |   |
|                                                                                                                                                                                 |   |                  |      |   |                   |   |   |   |
|              Total      current assets                                                                              |   |                  | 3,833,861 |   |                   |   | 3,832,941 |   |
|                                                                                                                                                                                 |   |                  |      |   |                   |   |   |   |
| PROPERTY AND      EQUIPMENT; net of      accumulated depreciation and amortization of $ 5,904,706 and      $5,883,861 at December      31, 2007 and September 30, 2007, respectively |   |                  | 403,846   |   |                   |   | 221,990 |   |
|                                                                                                                                                                                 |   |                  |      |   |                   |   |   |   |
|                                                                                                                                                                                 |   |                  |      |   |                   |   |   |   |
|                                                                                                                                                                                 |   |                  |      |   |                   |   |   |   |
| OTHER      ASSETS:                                                                                                                                                                   |   |                  |      |   |                   |   |   |   |
|                                                                                                                                                                                 |   |                  |      |   |                   |   |   |   |
| Long      Term Portion of Note Receivable                                                                                                                                            |   |                  | 612,500   |   |                   |   | -- |   |
| Other      Assets                                                                                                                                                                    |   |                  | 86,348    |   |                   |   | 80,160 |   |
|              Total      other assets                                                                                |   |                  | 698,848   |   |                   |   | 80,160 |   |
|                                                                                                                                                                                 |   |                  |      |   |                   |   |   |   |
| Total      Assets                                                                                                                                                                    |   | $                     | 4,936,555 |   |                   | $      | 4,135,091 |   |
|  The      accompanying notes are an integral part of the financial      statements.                                                                                   |   |

----

|                                                                                                                                                                                                                                                               |   | December      31,2007(Unaudited) |        |   | September      30,2007 |   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|----------------------------------|-------------|--------|------------------------|--------|
| LIABILITIES      AND STOCKHOLDERS' DEFICIT                                                                                                                                                                                                                         |   |                             |        |   |                   |   |
| CURRENT      LIABILITIES:                                                                                                                                                                                                                                          |   |                             |        |   |                   |   |
| Accounts payable and accrued      liabilities                                                                                                                                                                                                                      |   | $                                | 1,115,169   |   |                   | $      | 1,332,302 |   |
| Revolving line of      credit                                                                                                                                                                                                                                      |   |                             | 333,231     |   |                   |   | 340,000 |   |
| Deferred    revenue                                                                                                                                                                                                                                                |   |                             | 17,340      |   |                   |   | 17,691 |   |
| Note Payable – Itau      Bank                                                                                                                                                                                                                                |   |                             | 114,917     |   |                   |   | 16,388 |   |
| Total Current      Liabilities                                                                                                                                                                                                                                     |   |                             | 1,580,657   |   |                   |   | 1,706,381 |   |
|                                                                                                                                                                                                                                                               |   |                             |        |   |                   |   |   |   |
| LONG TERM      LIABILITIES:                                                                                                                                                                                                                                        |   |                             |        |   |                   |   |   |   |
| Note Payable – Itau      Bank                                                                                                                                                                                                                                |   |                             | 130,207     |   |                   |   | 18,200 |   |
|                                                                                                                                                                                                                                                               |   |                             |        |   |                   |   |   |   |
| Senior subordinated secured      convertible notes due September 30, 2009,     net of      unamortized discount of $125,948 and $143,575 at December 31,      2007    and  September      30, 2007, respectively |   |                             | 3,923,902   |   |                   |   | 3,906,275 |   |
| Total Long Term      Liabilities                                                                                                                                                                                                                                   |   |                             | 4,054,109   |   |                   |   | 3,924,475 |   |
| Total    liabilities                                                                                                                                                                                                                                               |   |                             | 5,634,766   |   |                   |   | 5,630,856 |   |
|                                                                                                                                                                                                                                                               |   |                             |        |   |                   |   |   |   |
| COMMITMENTS AND      CONTINGENCIES                                                                                                                                                                                                                                 |   |                             |        |   |                   |   |   |   |
|  STOCKHOLDERS’      DEFICIT                                                                                                                                                                                                                             |   |                             |        |   |                   |   |   |   |
|                                                                                                                                                                                                                                                               |   |                             |        |   |                   |   |   |   |
| Preferred stock, $0.01 par      value - 1,000,000 shares authorized; none issued                                                                                                                                                                                   |   |                             |        |   |                   |   |   |   |
|                                                                                                                                                                                                                                                               |   |                             |        |   |                   |   |   |   |
| Common stock, $.01 par value -      30,000,000 shares authorized; issued and outstanding:    15,325,281 at      December 31, 2007 and September 30, 2007                                                                                       |   |                             | 153,252     |   |                   |   | 153,252 |   |
| Additional paid-in      capital                                                                                                                                                                                                                                    |   |                             | 22,843,814  |   |                   |   | 22,842,290 |   |
| Accumulated      deficit                                                                                                                                                                                                                                           |   |                             | (23,580,532 | )      |                   |   | (24,353,140 | ) |
| Accumulated other      comprehensive loss- currency translation loss                                                                                                                                                                                               |   |                             | (25,108     | )      |                   |   | (48,530 | ) |
| Less treasury stock at cost;      100,000 shares at December 31, 2007 and September 30, 2007,      respectively.                                                                                                                                                   |   |                             | (89,637     | )      |                   |   | (89,637 | ) |
|  Total Stockholders’      Deficit                                                                                                                                                                                                                       |   |                             | (698,211    | )      |                   |   | (1,495,765 | ) |
| Total Liabilities and      Stockholders’ Deficit                                                                                                                                                                                                             |   | $                                | 4,936,555   |   |                   | $      | 4,135,091 |   |

----

|                                                                                                                                                                                         |   | 2007(unaudited) |       |   | 2008   |   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|-----------------|------------|--------|--------|--------|
|                                                                                                                                                                                         |   |            |       |   |   |   |
| Net      Sales                                                                                                                                                                               |   | $               | 1,539,845  |   |   | $      | 1,006,546 |   |
| Cost      of Sales                                                                                                                                                                           |   |            | 888,636    |   |   |   | 679,321 |   |
| Gross      Profit                                                                                                                                                                            |   |            | 651,209    |   |   |   | 327,225 |   |
|                                                                                                                                                                                         |   |            |       |   |   |   |   |   |
| Operating      Expenses:                                                                                                                                                                     |   |            |       |   |   |   |   |   |
| Selling, general and      administrative                                                                                                                                                     |   |            | 576,363    |   |   |   | 557,929 |   |
| Research and      development                                                                                                                                                                |   |            | 41,078     |   |   |   | 2,030 |   |
| Total operating      expenses                                                                                                                                                                |   |            | 617,441    |   |   |   | 559,959 |   |
| Total operating income (loss)      from continuing operations                                                                                                                                |   |            | 33,768     |   |   |   | (232,734 | ) |
| Other      income (expenses):                                                                                                                                                                |   |            |       |   |   |   |   |   |
| Interest expense (net),      including $17,626 and $16,658, respectively of debt discount      amortization                                                                                  |   |            | (88,410    | )      |   |   | (92,920 | ) |
| Other income      (expense)                                                                                                                                                                  |   |            | 352        |   |   |   | (9,612 | ) |
| Total other    expense                                                                                                                                                                       |   |            | (88,058    | )      |   |   | (102,532 | ) |
|                                                                                                                                                                                         |   |            |       |   |   |   |   |   |
| Net loss, before income taxes,      from continuing operations                                                                                                                               |   |            | (54,290    | )      |   |   | (335,266 | ) |
|                                                                                                                                                                                         |   |            |       |   |   |   |   |   |
| Income Tax    expense                                                                                                                                                                        |   |            | 29,548     |   |   |   | 5,549 |   |
| Net loss, from continuing      operations                                                                                                                                                    |   |            | (83,838    | )      |   |   | (340,815 | ) |
| Income (Loss), from      Discontinued Operations (includes a gain on the sale of    assets      in the amount of $1,094,817for the period ending December 31,      2007) |   |            | 856,446    |   |   |   | (19,577 | ) |
| Net      income (loss)                                                                                                                                                                       |   | $               | 772,608    |   |   | $      | (360,392 | ) |
|                                                                                                                                                                                         |   |            |       |   |   |   |   |   |
| Other      comprehensive loss, net of tax:                                                                                                                                                   |   |            |       |   |   |   |   |   |
| Foreign      currency translation adjustments                                                                                                                                                |   |            | 23,422     |   |   |   | (5,398 | ) |
| Comprehensive      income (loss)                                                                                                                                                             |   | $               | 796,030    |   |   | $      | (365,790 | ) |
|                                                                                                                                                                                         |   |            |       |   |   |   |   |   |
| Net      income (loss) per share, from continuing operations -Basic                                                                                                                          |   | $               | (.01       | )      |   | $      | (.02 | ) |
| Net      income (loss) per share, from continuing operations -    Diluted                                                                                                                    |   | $               | (.01       | )      |   | $      | (.02 | ) |
| Net      income (loss) per share, from discontinued operations -    Basic                                                                                                                    |   | $               | .06        |   |   | $      | -- |   |
| Net      income (loss) per share, from discontinued operations -      Diluted                                                                                                                |   | $               | .06        |   |   | $      | -- |   |
| Net      income (loss) per share - Basic                                                                                                                                                     |   | $               | .05        |   |   | $      | (.02 | ) |
| Net      income (loss) per share - Diluted                                                                                                                                                   |   | $               | .05        |   |   | $      | (.02 | ) |
| Weighed      average common shares used in calculation of net income (loss) per share -      Basic                                                                                           |   |            | 15,225,281 |   |   |   | 15,225,281 |   |
| Weighed      average common shares used in calculation of net income (loss) per share -      Diluted                                                                                         |   |            | 15,225,281 |   |   |   | 15,225,281 |   |

----

|                                                     |   | Three      Months EndedDecember      31 |     |
|----------------------------------------------------------|--------|-----------------------------------------|----------|
|                                                     |   | 2007(unaudited)                         |     |   | 2008 |   |
| Cash      flows from operating activities:               |   |                                    |     |   |   |   |
| Net      Income (Loss)                                   |   | $                                       | 772,608  |   |   | $ | (360,392 | ) |
| Adjustments      to reconcile net loss to net            |   |                                    |     |   |   |   |   |   |
| Cash      provided by operating activities:              |   |                                    |     |   |   |   |   |   |
| Depreciation and      amortization                       |   |                                    | 10,770   |   |   |   | 8,670 |   |
| Amortization of debt      discount                       |   |                                    | 17,627   |   |   |   | 16,042 |   |
| Gain on sale of      Assets                              |   |                                    | (834,817 | ) |   |   | -- |   |
| Bad Debt    Expense                                      |   |                                    | 33,000   |   |   |   | -- |   |
| Stock Based      Compensation                            |   |                                    | 1,524    |   |   |   | 4,895 |   |
| Changes      in operating assets and liabilities:        |   |                                    |     |   |   |   |   |   |
| Accounts      receivable                                 |   |                                    | 69,714   |   |   |   | 337,959 |   |
| Prepaid expenses and other      current assets           |   |                                    | (21,485  | ) |   |   | 10,198 |   |
| Inventories                                              |   |                                    | 380,259  |   |   |   | (215,746 | ) |
| Accounts payable and accrued      expenses               |   |                                    | (217,132 | ) |   |   | 146,361 |   |
| Other assets                                             |   |                                    | (6,190   | ) |   |   | -- |   |
| Deferred    revenue                                      |   |                                    | (351     | ) |   |   | (2,925 | ) |
| Net cash provided by (used in)      operating activities |   |                                    | 205,527  |   |   |   | (54,938 | ) |
|                                                     |   |                                    |     |   |   |   |   |   |
| Cash      flows from investing activities:               |   |                                    |     |   |   |   |   |   |
| Purchase      of property and equipment                  |   |                                    | (160,036 | ) |   |   | (1,502 | ) |
| Payments      Received on Notes Receivable               |   |                                    | 17,500   |   |   |   | -- |   |
| Net cash used in investing      activities               |   |                                    | (142,536 | ) |   |   | (1,502 | ) |
|                                                     |   |                                    |     |   |   |   |   |   |
| Cash      flows from financing activities:               |   |                                    |     |   |   |   |   |   |
| Net      payments on (borrowings) from Line of Credit    |   |                                    | (6,769   | ) |   |   | 50,000 |   |
| Net      borrowings on Notes                             |   |                                    | 210,536  |   |   |   | -- |   |
| Net cash provided by financing      activities           |   |                                    | 203,767  |   |   |   | 50,000 |   |
|                                                     |   |                                    |     |   |   |   |   |   |
| Effects      of foreign exchange rate                    |   |                                    | (9,169   | ) |   |   | (5,067 | ) |
|                                                     |   |                                    |     |   |   |   |   |   |
| Net decrease in cash and cash      equivalents           |   |                                    | 257,589  |   |   |   | (11,507 | ) |
|                                                     |   |                                    |     |   |   |   |   |   |
| Cash      and cash equivalents at beginning of period    |   |                                    | 6,593    |   |   |   | 150,663 |   |
|                                                     |   |                                    |     |   |   |   |   |   |
| Cash      and cash equivalents at end of period          |   | $                                       | 264,182  |   |   | $ | 139,156 |   |
| Supplemental      disclosure of cash flow information:   |   |                                    |     |   |   |   |   |   |
| Cash      paid during the period for interest            |   | $                                       | 81,528   |   |   | $ | 81,409 |   |

----

----

|                                  |   | Three      Months EndedDecember      31 |      |
|---------------------------------------|--------|-----------------------------------------|-----------|
|                                  |   | 2007                                    |      |   | 2006 |   |
| Convertible      notes                |   |                                    | 5,399,800 |   |   |   | 5,399,800 |   |
| Options      to purchase common stock |   |                                    | 2,267,014 |   |   |   | 2,362,514 |   |
| Total      antidilutive instruments   |   |                                    | 7,666,814 |   |   |   | 7,762,314 |   |

----

|                                               |   | Shares |      |   | Weighted      average exercise price |   |
|----------------------------------------------------|--------|--------|-----------|--------|--------------------------------------|--------|
|                                               |   |   |      |   |                                 |   |
| Options      outstanding – October 1, 2007   |   |   | 2,289,504 |   |                                 | $      | 1.11 |   |
| Granted                                            |   |   | --        |   |                                 |   | -- |   |
| Exercised                                          |   |   | --        |   |                                 |   | -- |   |
| Forfeited, cancelled or      expired               |   |   | 22,500    |   |                                 |   | 0.25 |   |
| Options      outstanding – December 31, 2007 |   |   | 2,267,014 |   |                                 | $      | 1.12 |   |
| Options      exercisable – December 31, 2007 |   |   | 2,132,014 |   |                                 | $      | 1.17 |   |

|                         |   | Three      Months EndedDecember      31, 2007 |   |
|------------------------------|--------|-----------------------------------------------|--------|
|                         |   | 2008                                          |   |   | 2007 |   |
| Dividend      yield          |   |                                          | --     |   |   |   | -- |   |
| Expected      volatility     |   |                                          | 85%    |   |   |   | 82% |   |
| Risk-free      interest rate |   |                                          | 4%     |   |   |   | 4% |   |
| Expected      life in years  |   |                                          | 5-10   |   |   |   | 5-10 |   |

----

|                                                                                                                                    |   | December      31,2007 |      |   | September      30,2007 |   |
|-----------------------------------------------------------------------------------------------------------------------------------------|--------|-----------------------|-----------|--------|------------------------|--------|
|                                                                                                                                    |   |                  |      |   |                   |   |
|                    Raw      Materials    |   | $                     | 1,435,244 |   |                   | $      | 1,510,204 |   |
|                    Work-in-process       |   |                  | 144,714   |   |                   |   | 163,218 |   |
|                    Finished      goods   |   |                  | 1,203,406 |   |                   |   | 1,481,295 |   |
|                                                                                                                                    |   |                  | 2,783,364 |   |                   |   | 3,154,717 |   |
|                    Less      reserves    |   |                  | (608,742  | )      |                   |   | (599,836 | ) |
|                    Inventories,      net |   |                  | 2,174,622 |   |                   |   | 2,554,881 |   |

----

|                                                 |   | United*States |      |   | Brazil |   |    | Consolidated |   |
|------------------------------------------------------|--------|---------------|-----------|--------|--------|--------|---------|--------------|--------|
| December      31, 2007:                              |   |          |      |   |   |   |    |         |   |
|      Revenues               |   |          | 1,011,822 |   |   |   | 528,023 |         |   |   | 1,539,845 |   |
|      Long-lived      assets |   |          | 794,985   |   |   |   | 307,709 |         |   |   | 1,102,694 |   |
|                                                 |   |          |      |   |   |   |    |         |   |   |   |   |
| December      31, 2006:                              |   |          |      |   |   |   |    |         |   |   |   |   |
|      Revenues               |   |          | 719,334   |   |   |   | 287,212 |         |   |   | 1,006,546 |   |
|      Long-lived      assets |   |          | 137,218   |   |   |   | 85,427  |         |   |   | 222,645 |   |

----

|                                                                                                      |   | 2007   |      |   | 2006   |   |
|-----------------------------------------------------------------------------------------------------------|--------|--------|-----------|--------|--------|--------|
| Net      sales,                                                                                           |   | $      | 217,161   |   |   | $      | 381,739 |   |
| Costs      of sales                                                                                       |   |   | 256,888   |   |   |   | 274,158 |   |
| Gross      Profit                                                                                         |   |   | (39,727   | )      |   |   | 107,581 |   |
|                                                                                                      |   |   |      |   |   |   |   |   |
|                                                                                                      |   |   |      |   |   |   |   |   |
| Operating      Expenses,                                                                                  |   |   |      |   |   |   |   |   |
|     Selling,      general and administrative                                          |   |   | 196,936   |   |   |   | 63,244 |   |
|     Research      and development                                                     |   |   | 1,708     |   |   |   | 63,914 |   |
|           Total      operating costs and expenses       |   |   | 198,644   |   |   |   | 127,158 |   |
|                                                                                                      |   |   |      |   |   |   |   |   |
|       Operating      (loss) income                                          |   |   | (238,371  | )      |   |   | (19,577 | ) |
|                                                                                                      |   |   |      |   |   |   |   |   |
| Other      income (expenses)                                                                              |   |   |      |   |   |   |   |   |
|       Gain      on Sale of Assets                                           |   |   | 1,094,817 |   |   |   | -- |   |
|             Total      other income (expense) |   |   | 1,094,817 |   |   |   | -- |   |
|                                                                                                      |   |   |      |   |   |   |   |   |
|       Net      income (loss) before income taxes                            |   |   | 856,446   |   |   |   | (19,577 | ) |
|                                                                                                      |   |   |      |   |   |   |   |   |
|          Income      Tax                                     |   |   | --        |   |   |   | -- |   |
|                                                                                                      |   |   |      |   |   |   |   |   |
| Net      income (loss) from discontinued operations                                                       |   | $      | 856,446   |   |   | $      | (19,577 | ) |

----

----

| · | Activities      related to upgrading the Analyst instrument and product offerings such as      evaluating and developing complimentary products for Hemagen’s Analyst      product line to distribute to the veterinary market and alternative tests      utilizing the Analysts’ rotor technology;and |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| · | Developing      new ELISA kits and enhancing existing ELISA  kits, |
|--------|--------------------------------------------------------------------|

| · | Developing      and enhancing IFA kits. |
|--------|-----------------------------------------|

----

----

----

|        Item      2.   |    Unregistered Sales of Equity      Securities and Use ofProceeds. |
|--------------------------------------|------------------------------------------------------------------------------------|

| Period                         | (a)Total      Number of       Shares  Purchased | (b)Average      PricePaid      per Share | (c)Total      Number of Shares      Purchased asPart      of PubliclyAnnounced      Plans orPrograms(1) | (d)Maximum      Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased      Under the Plans or Programs (2) |
|--------------------------------|----------------------------------------------------------------|------------------------------------------|--------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------|
| October      1-31, 2007        | 11,250                                                         | $0.19                                    | 11,250                                                                                                       | -                                                                                                                             |
| November      1–30, 2007 | 16,064                                                         | $0.22                                    | 16,064                                                                                                       | -                                                                                                                             |
| December      1-31, 2007       | 21,330                                                         | $0.19                                    | 21,330                                                                                                       | -                                                                                                                             |
| Total                          | 48,644                                                         | $0.20                                    | 48,644                                                                                                       | -                                                                                                                             |

|   | (1) | Represents      shares of Company’s Common Stock purchased pursuant to the Company’s      Employee Stock Ownership Plan (ESOP) that was established October 1, 2003      with no expiration.  The purpose of the plan is not to      repurchase, but rather is an employee benefit  plan. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | There      is no maximum number of shares that may be purchased under the Company’s      Employee Stock Ownership Plan. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------|

----

| Exhibit      31.1    | Certification      of Chief Executive Officer pursuant to Rule 13a-14(a)                                                            |
|-------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------|
|                                |                                                                                                                                |
| Exhibit      31.2         | Certification      of Principal Financial Officer pursuant to Rule  13a-14(a)                                                       |
|                                |                                                                                                                                |
| Exhibit      32.1         | Certification      of Chief Executive Officer pursuant to Section 1350 of Chapter 63 of Title      18 of the United States Code     |
|                                |                                                                                                                                |
| Exhibit      32.2         | Certification      of Principal Financial Officer pursuant to Section 1350 of Chapter 63 of      Title 18 of the United States Code |

----

|              | Hemagen Diagnostics,      Inc.   |
|-------------------|----------------------------------|
|              | (Registrant)                     |
|              |                             |
|              |                             |
| February 14, 2008 | /s/William P. Hales              |
|              | William      P. Hales            |
|              | President      and               |
|              | Chief      Executive Officer     |
|              |                             |
|              |                             |
| February 14, 2008 | /s/Catherine M. Davidson         |
|              | Catherine      M. Davidson       |
|              | Principal      Financial Officer |